LimFlow, Inc.
- Home
- Companies
- LimFlow, Inc.
- Products
- LimFlow - Chronic Limb- Threatening ...
LimFlow - Chronic Limb- Threatening Ischemia (CLTI) Technology
FromLimFlow, Inc.
Living with Peripheral Artery Disease (PAD) that progresses to CLTI is challenging. Life revolves around chronic leg pain that can become unbearable over time. The end stage of the disease is characterized by non-healing foot ulcers that considerably lessen mobility and quality of life.
Most popular related searches
peripheral arterial disease
limb ischemia
chronic pain
leg pain
disease pad
limb amputation
peripheral arterial
arterial disease
wound healing
disease progression
Finally, and often after several medical interventions, the result is major amputation of the lower leg to resolve chronic pain and non-healing wounds, or to prevent progression of gangrene and sepsis. Major limb amputation is a drastic, life-changing step, and LimFlow was designed to provide a new option for these patients.
About Amputation
2 min
Every 2 Minutes a Leg is Amputated1,2 (In U.S. and Europe)
45%
35-45% of Patients Go Straight to Amputation Without CLTI Diagnosis1,3
Once Amputated
10%
Die Before Leaving Hospital4
50%
50% of patients with amputation secondary to PAD die in 12-24 months5
37%
20-37% Have Major Complications4
